A recent study compared levels of plasma tau and NfL as cross-sectional and longitudinal markers of cognitive decline and neuroimaging changes, on a cohort of 995 subjects from the community-based Mayo Clinic Study of Aging (MCSA) (82). This evidence concerns the gene MAPT and Mental deterioration.